The potential of phytotherapy in oncology: a review
DOI:
https://doi.org/10.14450/2318-9312.v37.e1.a2025.pp6-14Keywords:
Phytotherapy, Cancer, Medicinal Plants, Phytochemicals, complementary therapiesAbstract
Cancer still leads the world as a mortality and morbidity ratio. Conventional treatments are constantly used, such as radiotherapy, chemotherapy and surgeries, however, there are adverse effects, phytotherapy is characterized by the study of medicinal plants and their potential use. In this context, this study aims to verify in the literature the use of herbal medicines in oncology and mechanisms of action. This is an integrative literature review with the purpose of verifying in the literature the guiding theme: the use of herbal medicines in oncology. The database used for the research was: Medline (Medical Literature Analysis and Retrieval System Online). The descriptors used for the search were based on the Health Sciences Descriptors (DeCs), namely: "Oncology" and "Phytotherapy". Among the articles researched, only 8 met the criteria established for the study. Among the main pharmacological components mentioned in the articles and with antitumor activity are: Resveratrol, Cannabidiol, Flavanol Glycosides, Gingerol and Curcumin. It was possible to verify that there is a diversity of medicinal plants that can be used in oncology, as well as it was also demonstrated that bioactive products such as Resveratrol, Cannabidiol, Flavanol Glycosides, Gingerol and Curcumin have antitumor activities.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Flávio Freitas Soares Filho, Alice de Sa Ferreira

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).